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Abstract 
Diffuse malignant mesothelioma (DMM) of the pleura is a rare and aggressive disease, where the 
long-term survival (LTS) rate is low. The epithelioid subtype is the most prevalent form of DMM 
with the best prognosis. In order to study prognostic histopathologic factors associated with 
extended survival in epithelioid DMM, we examined 43 tumors from patients with survival over five 
years (long-term survivals [LTS]) and compared the findings with 84 tumors from a reference group 
with average survival (RG). We analyzed the tumors considering previously published 
histopathological prognostic features and attempted to identify additional morphological features 
predictive of extended survival. Most of the LTS tumors presented with nuclear grade I (n = 
34,90%) and a tubulopapillary growth pattern (n = 30,70%). One LTS tumor had necrosis. In 
contrast, nuclear grade II (n = 49,61%) and solid growth pattern (n = 59,70%) were more frequent 
in RG, and necrosis was present in 16 (19%) tumors. We also evaluated the association of 
asbestos lung tissue fiber burden quantified from autopsy samples with histopathological features 
and found that elevated asbestos fiber was associated with higher nuclear grade (p < 0.001) and 
the presence of necrosis (p = 0.021). In univariate survival analysis, we identified the following 
three novel morphological features associated with survival: exophytic polypoid growth pattern, 
tumor density, and single mesothelium layered tubular structures. After adjustments, low nuclear 
grade (p < 0.001) and presence of exophytic polypoid growth (p = 0.024) were associated with 
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1. Introduction 
Diffuse malignant mesothelioma (DMM) of the pleura is a rare tumor, occurring mainly after 
asbestos exposure [1]. DMM is the most frequent type of mesothelioma. Other mesothelioma 
types, with a better prognosis, includes localized malignant mesotheliomas and well-differentiated 
papillary mesotheliomas (WDPMs). DMM is histologically divided into three main subtypes, 
namely: epithelioid, biphasic, and sarcomatoid [2]. Many studies have shown that histology is the 
most important prognostic marker and that the epithelioid subtype is the most common type and it 
has the best prognosis [1,3]. The largest prospectively collected report revealed a median survival 
of 13 months in unselected epithelioid DMM patients, whereas a study on surgically treated 
epithelioid DMM patients reported a median survival of 19 months [1,4]. 
Long-term survivals (LTS) in pleural DMM has been previously studied primarily in patients 
undergoing  surgical or multimodality therapy [5–7]. Young age, female gender, epithelioid 
subtype, and the type of surgery were observed to predict long-term and cancer-specific survival in 
these surgically fit patients. To the best of our knowledge, no study has systematically evaluated 
the histopathological findings of LTS. 
Several different prognostic features have been reported for the epithelioid subtype. Arguably, the 
best-characterized prognostic marker is the nuclear grading scale, which uses a combination of 
nuclear atypia and mitotic count. Several studies have recognized this scale as an independent 
predictor of survival in both pleural and peritoneal mesothelioma [8,9]. Histological subtyping of 
epithelioid DMM is another previously reported prognostic factor; pleomorphic and solid 
morphological subtypes are associated with aggressive behavior, whereas trabecular or 
tubulopapillary growth pattern have a better prognosis [10]. In addition, the absence of necrosis 
and pronounced myxoid stroma is associated with better survival [11,12]. Currently, these factors 
are not included in the classification of tumors of the pleura [2]. However, it has recently been 
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proposed that nuclear grading, architectural features of mesotheliomas, and other prognostic 
indicators should be routinely included in the classification of mesotheliomas [13]. 
In this study, we sought to determine histopathological features predictive of survival over five 
years in a group of patients with DMM of the pleura. To accomplish this, we used published 
morphological features and sought to identify novel features associated with prolonged survival.  
 
2. Materials and Methods 
2.1 Patients  
A description of the mesothelioma patient cohort in this study has been previously published [14]. 
Briefly, a total of 1010 patients with DMM of the pleura from the years 2000 to 2012 were identified 
from the Finnish Cancer Registry. From this group of patients, we identified those with survival that 
exceeded five years. We evaluated the original pathology reports of the mesotheliomas that 
fulfilled the criteria for DMM, including a full set of immunohistochemistry (IHC). We excluded one 
case of clerical error in the cancer registry, two WDPMs, and two localized malignant 
mesotheliomas (better prognosis is thought to be related to the lack of diffuse spread, while the 
histology is considered to be undistinguishable from DMM), and two non-pleural samples (the 
location might affect the histological picture of metastatic tumors). The remaining tumors were 
assigned to the LTS group. For comparison, we included a group of pleural DMMs with average 
survival from the same cohort as the LTS patients; these patients formed the reference group 
(RG). Only the epithelioid subtype was included in the RG, as all the LTS were epithelioid tumors. 
We also had access to the clinical and radiological information of these patients [15]. Survival is 
calculated from the first biopsy that was diagnostic for DMM and the study follow-up ended on 9 
September 2018.  
According to Finnish law, a forensic evaluation of the cause of death should be performed if death 
is suspected to have been caused by an occupational disease. In some of the cases, asbestos 
fiber analysis of lung tissues from these forensic autopsies was available. The asbestos analyses 
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were made by the Finnish Institute of Occupational Health using transmission electron microscopy 
(TEM). The fiber counts are quantified as million fibers per gram of dry lung (mf/g). 
Approval to use tissues and patient information was received from the national authority, Valvira 
(752/06.01.03.01/2016), and the Finnish Institute for Health and Welfare. The study protocol was 
approved by the local Institutional Review Board and the Ethics Committee of the Hospital District 
of Helsinki and Uusimaa (418/13/03/02/2015).  
 
2.2 Histopathological evaluation 
In many cases, multiple biopsy had been taken and tumor material was also available from surgical 
specimens. In general, the first histological sample that resulted in the unequivocal diagnosis of 
malignant mesothelioma was studied. If the sample included several tissue blocks, all were studied 
but one slide was selected to represent the sample. A more representative sample was evaluated 
instead of the diagnostic biopsy if it was obtained within three months of the first sample and if the 
initial biopsy sample was marginal. A senior pathologist (H.W) with experience in mesothelioma 
diagnostics scored the histopathological samples in a blinded fashion using a structured scoring 
sheet. Another experienced pulmonary pathologist (M.M) provided a second opinion in cases 
where significant differential diagnostic possibilities existed. The tumor samples were classified by 
size (large, small, and scant) as part of the scoring. The large biopsies included surgical material 
and material from surgical biopsies. The small biopsies included thick needle-biopsies and other 
small biopsies. The tumor sample was classified as scant if it was marginally sufficient for the 
diagnostic evaluation. If sufficient tumor tissue was available, we constructed formalin-fixed 
paraffin embedded tissue microarray (TMA) blocks. We performed IHC staining for BRCA-
associated protein 1 (BAP1) from these TMA samples [16]. 
The nuclear grade was assessed by a previously published method, where the nuclear atypia and 
the mitotic count were separately scored and then summed to yield the nuclear grade [8]. The 
nuclear size and irregularity were first evaluated at 400x magnification and graded from one to 
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three (1 = mild, 2 = moderate, 3 = severe atypia). After identifying the spots with the highest mitotic 
activity, the mitoses were then counted in 50 high-power fields (HPF) and counted as an average 
per 10 HPF. Six (4%) patients had only small areas of viable tumor, but reliable mitotic count could 
be assessed in the equivalent of 10 full HPFs. In eight (6%) cases, this could not be assessed due 
to inadequate sample size. The tumors were then divided into a 3-point mitotic score as follows: 1 
= low mitotic count (0-1/10 HPF), 2 = intermediate mitotic count (2-4/10 HPF) and 3 = high mitotic 
count (>5/10 HPF). Finally, the nuclear grade was assessed follows: grade I = score 2-3, grade II = 
score 4-5, grade III = score 6. 
The epithelioid morphological subtypes were recorded as five percentage increments and the 
tumors were classified by predominant growth pattern (trabecular, tubulopapillary, solid, 
micropapillary, pleomorphic). We classified these subtypes into “low-grade” (trabecular, 
tubulopapillary) or “high-grade” (solid, micropapillary, pleomorphic) by their dominant (>50%) 
pattern in survival analyses according to previous publications [10,17].  
In addition, for each tumor sample, we recorded the number of tumor sample blocks, sample type, 
tumor density (% tumor in the sample), superficial growth of the tumor (not applicable to small 
biopsy), presence of necrosis, invasiveness and invasion to adjacent structures, myxoid stroma 
(positive if it contains >50% of the tumor volume), nucleoli size (inconspicuous, conspicuous <3µm, 
large >3µm), cytological type (microcystic, clear cell, deciduoid, small cell) and tumor (scale 0-3), 
or pleural inflammatory infiltrate (positive, negative).  
To provide more stratification in the evaluation, we noted the relative presence of tubular structures 
covered with a single layer of mesothelial cells (single layer) (Figure 1F). We also decided to 
record presence of exophytic growth, stout fibrovascular papillae referred to as polypoid in the text, 
sometimes forming confluent areas or polyp-like structures (Figure 1A, B, C). Sometimes exophytic 
growth presented as delicate papillary structures and this was noted separately. Furthermore, we 
noted the presence of large tubular structures (large tubule, Figure 1D, E). These features were 
recorded as being present (if any of these features were noted) or absent if none was seen. The 
complete list of all evaluated features with definitions and explanations is found in Supplementary 
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Table 1. The tumor slides were examined, and pictures taken with a Leica 4000B microscope 
equipped with a Leica DFC 480 camera.  
2.3 Statistical analysis 
Categorical variables are presented as number of patients with percentage and the differences 
between the study groups were analyzed by chi-square test. Continuous variables are expressed 
as median with interquartile range (IQR) and statistical differences were tested by non-parametric 
Mann-Whitney U-test or Kruskal-Wallis test as indicated in the tables. The Bonferroni correction for 
multiple tests was used if multiple comparisons were made. Bivariate correlations were assessed 
using the Spearman correlation coefficient. Cox proportional-hazards univariate and multivariate 
survival analysis was used to assess how histopathological factors predict survival.  Age and 
gender were used as covariates in multivariate models. Based on our findings on the impact of 
treatment on prognosis, the survival analyses were adjusted with treatment status (Paajanen et al, 
submitted). The results of survival analysis are presented as hazard ratios (HR) and associated 
95% confidence intervals (CI). Statistical analyses were performed using IBM Statistics 25.0 (IBM 
SPSS Statistics, Chicago, IL). P-values < 0.05 were considered significant. 
 
3. Results 
3.1 Histopathological factors related to the patient groups 
A total of 127 tumor specimens in patients with pleural DMM were analyzed. From these patients, 
43 (34%) were LTS and 84 (66%) formed the RG. A median of three (IQR 1-5) hematoxylin and 
eosin-stained (H&E) slides were reviewed from each tumor. The analyzed sample was from 
pneumectomy in 5 (4%), surgical biopsy in 84 (66%), and thick-needle or other types of non-
surgical biopsies in 38 (30%) cases. We classified 42 (33%) samples as being small, out of which 
seven (6%) were evaluated as scant. There were no significant differences in the distribution of 
small samples between the study groups (LTS: n = 10, 23% and RG: n = 32, 38%; p = 0.093). The 
presence of tumor invasion in the evaluated samples (95% in LTS and 92% RG) was similar in the 
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study groups (p = 0.444). The tumor sample size affected the frequency of invasion; all nine 
tumors with no invasion were associated with small samples (p < 0.001). BAP1 IHC was available 
in 57 (45%) patients and was negative in 12/14 (86%) LTS patients and 25/43 (58%) in RG 
patients (p = 0.150).  
The main histopathological differences between the groups are summarized in Table 1. LTS 
tumors presented mostly with tubulopapillary growth pattern with nuclear grade I. In contrast, a 
solid growth pattern and grade II were more common in the RG (p < 0.001). Only 1/12 (1%) tumors 
with exophytic polypoid patterns was seen in the RG tumors (p < 0.001). We did not find 
differences in the presence of diffuse exophytic growth (p = 0.053), superficial growth of the tumor 
(p = 0.130), tumor invasion into adjacent structures (p = 0.627), nucleoli size (p = 0.415), tumor (p 
= 0.380) or pleural inflammation (p = 0.386), or cytological features (p = 0.412). A sensitivity 
analysis was performed after removing small biopsy samples, but this did not affect the 
distributions between study groups (data not shown). Not surprisingly, the sample size affected the 
presence of large tubules (none in small samples; p = 0.015) and exophytic polypoid growth (one 
in small samples; p = 0.052). Tubules with a single layer of the mesothelium were also more 
common in larger samples (n = 38, 45% versus n = 12, 29%), but the difference was less distinct 
(p = 0.080). 
3.2 Histopathological features and their association with overall survival 
The median survival for LTS was 79.3 months (IQR 69.3 – 99.3 months) and for the RG 11.3 
months (IQR 5.6 – 19.2 months). None of the RG and eight (19%) LTS patients were alive at the 
end of the study follow-up. Out of these patients, two had only minimal signs of DMM in their last 
follow-up visits; one had no signs of recurrence after surgery, while other one was lost to follow-up 
before study closure. Other six patients had either progressive multifocal clinical or radiological 
findings matching DMM. The follow-up of the LTS patients is summarized in Table 2.   
The nuclear grade, histologic subtype, tumor density and the presentation of necrosis, exophytic 
polypoid growth, and single layer predicted survival in univariate survival analysis (Table 3). We 
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found that both mitosis (HR 1.16, 95% CI 1.11 – 1.22) and nuclear atypia (moderate versus mild 
atypia: HR 1.97, 95% CI 1.16 – 3.33 and severe versus mild atypia: HR 3.13, 95% CI 1.64 – 5.99) 
had prognostic value when nuclear grade was separated to its initial factors. The multivariate 
analysis was adjusted on these significant markers along with age, gender, and treatment 
information. The findings are presented in Table 4. In summary, we found that low nuclear grade 
and the presence of exophytic polypoid growth pattern were the only independent prognostic 
factors for longer survival.  
As the differential diagnosis between DMM with papillary features and WDPM, including WDPM 
with invasive foci is demanding [2,18], we re-evaluated the tumors with polypoid changes. In 2/14 
(14%) cases, the first biopsy that resulted in the original diagnosis of DMM was on re-evaluation 
compatible to a WDPM, and these patients were subsequently excluded from the analyses. In 
addition, in 3/14 (21%) cases, the diagnosis of WDPM with invasive foci could be considered. All 
three cases showed invasion within the papillary myxoid stroma and in one of the cases a minor 
invasive focus in the adipose tissue. As these WDPM-like tumors originally had been diagnosed as 
DMM, and their clinical behavior was similar to the others in the group of tumors with polypoid 
features, they were included as DMM:s for the statistical evaluation. The survival analyses were 
also performed after removing these three patients and is shown in Supplementary Table 3. This 
additional model reduced the statistical significance of polypoid features (p = 0.057), without 
affecting other results. In the other cases, the histological picture indicated the diagnosis of DMM 
of the pleura. The individual clinical information and outcomes of patients with polypoid features is 
shown in supplementary Table 2.  
3.3 Asbestos fiber count and its association with histopathological parameters 
In a separate study, we evaluated the association of asbestos fiber count and LTS (Paajanen et al 
submitted). We observed that the LTS patients had less asbestos fiber in lung tissues than the RG. 
However, asbestos fiber analysis was available from just 14 (33%) of the LTS group and 60 (71%) 
from the RG. The overall median concentration was 3.95 mf/g (IQR 0.40 – 77.50 mf/g). We found 
an association with the total concentration of lung fibers and nuclear grade (p < 0.001, Figure 2). 
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When nuclear grade was separated into its initial factors, we found an association with asbestos 
concentration and mitosis (r = 0.41; p = 0.001), but not with nuclear atypia (p = 0.071). In addition, 
higher tissue fiber content was more likely to be found in tumors with necrosis (median 64.50 mf/g, 
IQR 3.40 – 182.50 mf/g versus median 1.90 mf/g, IQR 0.40 – 24.75 mf/g; p = 0.021). No other 
relevant associations were found between the fiber concentration and histopathological findings. 
4. Discussion 
As the epithelioid subtype is the most common in DMM and is associated with the best prognosis, 
several attempts have been made to further characterize these tumors. The heterogeneity in 
histology and inconsistent clinical behavior of these tumors complicates the prognostic evaluation 
in clinical practice. In this study, we identified several histopathological factors that are associated 
with a more indolent tumor type. Nuclear grade I, low grade histological subtype, lower tumor 
density, absence of necrosis among with the presence of polypoid exophytic growth, large tubules 
and tumor growth on single layer were more prevalent in LTS tumors. In contrast, we did not 
observe a survival association with tumor myxoid stroma (not including myxoid in exophytic 
polypoid structures), tumor superficial growth, nucleoli size, the level of invasion in the initial 
biopsy, invasion to adjacent structures, cytological type, or inflammatory cells. 
 
The separation of benign from malignant mesothelial proliferation can sometimes be challenging, 
especially with limited low-quality diagnostic samples. Tumor invasion of the stroma is considered 
to be central for diagnosing DMM; if such invasion is absent atypical mesothelial hyperplasia or 
mesothelioma in situ should be considered as an initial diagnosis [2,19]. However, an epithelioid 
DMM diagnosis can be made from cytological samples (where invasion cannot be evaluated) if 
IHC and clinical and radiological characteristics are consistent with invasive DMM [20]. In our 
evaluation, invasion could not be seen in nine tumor samples; all of which were in small biopsies. 
However, there were no differences in the presence of invasion between the study groups and the 
presence of invasion did not predict survival in crude analyses. We assessed the clinical behavior 
of the LTS patients that had no evident invasion: they had either radiological or thoracoscopical 
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signs of DMM and one had re-biopsy that was consistent with invasive DMM. Small sample size 
can be seen to increase the possibility of mesothelial proliferations as DMM. However, in this study 
small sample size was more prevalent in the LTS group than the RG group. BAP1 loss detected in 
IHC can distinguish between benign and malignant mesothelial proliferation: malignant 
mesotheliomas are often negative for BAP1, while reactive and normal mesothelium, 
adenomatoids, and at least most WDPMs are positive [2,16,21]. We were able to stain 45% of the 
tumors for BAP1. Negativity for BAP1 was more frequent in the LTS group than in the RG, 
although the difference was not significant. During follow-up, all but two patients (one of which was 
lost to follow-up) presented with additional findings consistent with DMM. Taken together, we are 
confident that the results of this study cannot be explained by misdiagnosis of reactive mesothelial 
changes as DMM [22].    
 
The three-tier nuclear grading score is a previously published independent predictor for survival, 
which combines nuclear atypia and mitotic count [8]. The initial studies on this grading system 
were conducted primarily with larger surgical samples, but similar prognostic impact has also been 
observed with smaller pleural biopsy samples [11]. Similarly, it has been linked to better prognosis 
in epithelioid peritoneal mesothelioma [9]. In this study, we confirmed that nuclear grade is an 
independent prognostic marker in epithelioid DMM. The presence of nuclear grade I in LTS tumors 
was over twice that of the control group. The advantage of nuclear grading is that it is easy to 
perform on basic H&E-stained slides. However, the assessing nuclear atypia is subjective, and 
mitosis count can be time-consuming and prone to errors [23]. These problems could be solved 
with computer-assisted automation, which have shown superior reproducibility and good 
correlation with other pathological reviews [24].  
 
Stratifying epithelioid DMMs into secondary morphological subtypes is another previously reported 
prognostic marker. This approach has strong reproducibility with good interobserver agreement 
[25]. Previous reports have shown differences in the prevalence of these subtypes, which may be 
due to differences in the sample sizes used in these studies. For example, Brcic et al found that 
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the solid subtype was the most prominent and only some tumors were characterized as a 
micropapillary, trabecular, or pleomorphic [25]. Kadota et al, used mainly larger surgical specimens 
and observed that other subtypes were more constantly distributed [10]. When we combined all 
tumors, we observed that the solid subtype was the most frequent (54%) followed by the 
tubulopapillary subtype (43%); only single tumors were micropapillary, pleomorphic, or trabecular. 
For survival analyses, we combined these into “low-grade” and “high-grade” in accordance with 
previous publications [10,17]. These low-grade compounded subtypes were more common in LTS-
tumors when compared to the RG. The survival analysis showed significant findings only in 
univariate analysis but not after adjustments. As stratifying tumors into secondary morphological 
subtypes has been shown to be reproducible and simple to perform, we believe this approach 
should be further investigated and employed, either alone or in combination with other prognostic 
markers.  
 
The prognostic value of histological tumor necrosis has been shown in various solid malignancies 
[26]. Similar results have been published in pleural DMM [11]. In addition, a multi-institutional study 
revealed that overall survival was further stratified when the nuclear grade was added to the 
presence of necrosis [27]. We found necrosis only in one LTS tumor in contrast to sixteen in the 
control group. The proportion of necrosis in the control group was similar to the study of Habougits 
but was too low to reliably test the combination with nuclear grade [11]. The low prevalence of 
necrosis could also explain the significance in univariate analysis but not in multivariate analysis.  
 
We also attempted to identify novel histological parameters to further define tumor differentiation. 
The feature designated polypoid exophytic growth in the scoring was an independent prognostic 
factor in multivariate analysis (Figure 1A, B, C), although its significance diminished in sensitivity 
analyses (Supplementary Table 3). In contrast, the exophytic delicate papillary diffuse growth had 
no prognostic value. These polypoid features are similar to those seen in WDPM [22]. The 
differential diagnosis between pleural DMM with papillary formations with broad fibrovascular cores 
and pleural WDPM is challenging, especially for a recently introduced group of WDPM with limited 
13 
 
invasion. Thus, we evaluated the polypoid tumors in this regard and observed that 3/14 could be 
considered to exhibit features of WDPM including three cases with limited invasion (Supplementary 
Table 2) [2,18]. As noted earlier, we have excluded two cases of classical WDPM from the main 
analyses. The peritoneal WDPM occurs typically in women and is not associated with asbestos 
exposure and it has a relatively good prognosis [28]. WDPM in pleura is less common and seems 
to have a degree of association with asbestos. When comparing to peritoneal WDPM, pleural 
cases seems to be more aggressive, including cases that subsequently behave as DMM [22]. Our 
findings are consistent with this observation: the deaths of four patients with WDPM-like features 
were attributed to DMM and the only one alive had clear signs of diffuse invasive disease. IHC for 
BAP1 was available and negative in three of the WDPM cases. Interestingly, it has been reported 
that while BAP1 negativity is rare in WDPM, it is associated with synchronous or metachronous 
DMM [29]. Germline BAP1 loss is associated with an inherited predisposition to mesothelioma as 
well as other tumors. Mesotheliomas with germline BAP1 loss have a better overall survival 
compared with mesothelioma patients without these mutations [30]. It is possible that germline 
BAP1 mutations could explain in part the prolonged survival in the LTS group. Although the 
presence of these exophytic polypoid structures seem to predict prolonged survival, patients with 
this feature developed progressive DMM with the median survival of 70 months. Somewhat 
surprisingly, the outcome was similar in cases compatible with WDPM, WDPM with focal invasion, 
and DMM with polypoid features (Supplementary Table 2). This suggests that the presence of 
these polypoid features in mesothelial lesions seem to be more closely associated with the survival 
than the degree of tumor invasiveness, although the low number of cases preclude definite 
conclusion. On the other hand, the finding of pleural WDPM seems to have predicted a fully-
fledged DMM in these cases, as also indicated by an earlier study on pleural DMM [22]. 
We attempted to estimate the amount of tumor within the diagnostic sample, identified as tumor 
density. The tumor density was smaller in LTS and prognostic in univariate survival analysis but 
not after adjustments.  Another feature associated with LTS was the presence of large tubular 
structures covered with mesothelial cells (Figure 1 D, F).  The nature of these structures is unclear. 
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In addition to being large tubular structures a possibility could be distended lymphatic vessels 
covered with mesothelial cells. Although these structures were more frequent in LTS tumors, the 
proportions were low in both groups. Another morphological finding was growth of mesothelium in 
a single layer in tubular structures (Figure 1E). This was also more frequently observed in the LTS 
group. This finding only had prognostic value in univariate analysis (HR 0.52) if present and is 
probably related to the degree of differentiation in the tumor since normal mesothelium occurs in a 
single layer. This is also analogous to findings in well-differentiated adenocarcinomas where the 
glandular structures often are described to be in a single layer.  
The role of asbestos in DMM development is firmly established, although its prognostic 
significance has been debated [31,32]. Previously we have observed that LTS patients had a lower 
amount of asbestos fibers in the lung tissue compared to the RG, and here we studied the 
association between asbestos fiber burden and histopathological features. We found that the 
concentration of asbestos fiber was associated with nuclear grade, which was driven by correlation 
to mitotic count. In addition, the amount asbestos fiber count associated with tumor necrosis.  
4.1 Conclusions 
We identified several histopathological parameters that are associated with LTS. We confirmed 
previous reports that low-grade histopathological subtypes (tubulopapillary or trabecular) along 
with low nuclear grade and the absence of necrosis have better prognosis. In addition, we present 
new morphological findings that are associated with LTS. The presence of polypoid growth pattern 
along with nuclear grade were the only independent predictive factors for survival. Taken together, 
we believe that the features discussed in the article may be helpful in predicting prognosis in DMM. 
Whether these prognostic factors affect the efficacy of various treatment modalities remains to be 
studied. 
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Univariate determinants of survival using Cox proportional hazard model. 1. HR, hazard ratio; 2. 

















Table 3. Univariate analysis associated with overal l survival  
Variable  HR¹ (95% CI²) p-value    
Nuclear grade 
   Grade I 
   Grade II 
   Grade III 
 
1.00 






Histologic subtypes, low-grade 0.43   (0.30-0.62) <0.001   
Necrosis, yes 2.48   (1.45-4.23) 0.001   
Exophytic polypoid growth, yes 0.43   (0.23-0.80) 0.008   
Single layer, yes 0.52   (0.35-0.75) 0.001   
Large tubule, yes 0.72   (0.37-1.37) 0.312   
Myxoid stroma, yes 0.96   (0.44-2.06) 0.908   
Invasion, yes 1.33   (0.65-2.74) 0.434   
Tumor density (continuous) 
   
1.01   (1.01-1.02) 
 
0.001   
 
 
P-values are for the comparison of LTS and RG and were calculated by chi-square tests except for 
*, where Mann-Whitney U-test was used. 1. LTS, long-term survival over five years; 2. RG, 
reference group; 3. Histologic subtypes combined for survival analyses: high-grade (solid, 
micropapillary), low-grade (trabecular, tubulopapillary) 
 




LTS¹ RG2 p-value   
Nuclear grade, n (%) 
   Grade I 
   Grade II 
   Grade III 
 
34 (90%) 










Histologic subtypes, n (%) 
  Trabecular 
  Tubulopapillary 
  Solid 
  Micropapillary 
 
2   (5%) 
30 (70%) 
9   (20%) 





1   (1%) 
<0.001  
Compound histologic subtype3, n (%) 
   High-grade 










Myxoid stroma, n (%) 
   Absent 
   Present 
 
40 (93%) 
3   (7%) 
 
80 (95%) 
4   (5%) 
0.605  
Necrosis, n (%) 
   Absent 
   Present 
 
42 (98%) 





Novel parameters     
Exophytic polypoid growth pattern, n (%) 
   Absent 






1   (1%) 
<0.001  
Large tubule, n (%) 
   Absent 
   Present 
 
36 (84%) 
7   (16%) 
 
80 (95%) 
4   (5%) 
0.029  
Single layer, n (%) 
   Absent 








Tumor density, %, median (IQR)    50.0 (30 – 60) 
 




Table 2. Survival data of long-term survival (n = 43) 












signs of DMM 
Values 79.3 (69.3-99.3) 32 (74%) 3 (7%) 6 (14%) 2 (5%) 
 




Cox proportional hazard model adjusted for age, gender, nuclear grade, histologic subtypes, 
necrosis, exophytic polypoid growth, single layer, tumor density, and treatment; 1. HR, hazard 

















Table 4. Multivariate analysis associated with over all survival  




   Grade I 
   Grade II 
   Grade III 
1.01   (0.98 – 1.03) 
1.25   (0.71 – 2.18) 
 
1.00 
4.43   (2.51 – 7.82) 




Histologic subtypes, low-grade 0.71   (0.39 – 1.26) 0.241 
Necrosis, yes 1.26   (0.66 – 2.42) 0.484 
Exophytic polypoid growth, yes 0.43   (0.21 – 0.89) 0.024 
Single layer, yes 0.76   (0.46 – 1.26) 0.288 




Figure 1. Histologic features of epithelioid diffuse malignant mesothelioma of the pleura 
(hematoxylin and eosin stain). A, papillary myxoid lesion with invasion. B, thick confluent area of 
partially myxoid exophytic mesothelial growth. C, tip of large exophytic polypoid-like lesion with 
internal mesothelial growth. D, large tubular structures in the pleura. E, higher enlargement of large 
tubular structure seen in previous picture. F, tubular structures covered mostly with a single layer 
of mesothelium.  
Figure 2. The boxplot shows asbestos fiber content in patients divided by nuclear grade. The 
median concentration in grade I (n = 27) was 0.60 mf/g (IQR 0.20 – 8.60 mf/g), grade II (n = 39) 
13.0 mf/g (1.0 – 140.0 mf/g), and grade III (n = 3) 280.0 mf/g (150 – NA mf/g). The Kruskall-Wallis 
test showed a p-value < 0.001. The p-values in pairwise comparisons showed in the figure were 
adjusted with Bonferroni correction for multiple tests. 
 
Highlights 
• A small portion of epithelioid DMM patients presents with prolonged survival  
• Low nuclear grade and low-grade histological subtypes associates with better prognosis 
• Polypoid features found in WDPM can also be found in cases of DMM 






Juuso Paajanen:  Conceptualization, Methodology, Investigation, Writing – Original Draft Sanna 
Laaksonen: Conceptualization, Writing – Review & Editing Eeva Kettunen: Investigation, Writing 
– Review & Editing Ilkka Ilonen: Conceptualization, Resources, Writing – Review & Editing, 
Project administration Tapio Vehmas: Methodology, Writing – Review & Editing  Jarmo Salo: 
Conceptualization, Writing – Review & Editing Jari Räsänen: Conceptualization, Writing – Review 
& Editing Eva Sutinen: Investigation Hely Ollila: Investigation, Writing – Review & Editing Mikko 
I. Mäyränpää: Conceptualization, Methodology Investigation, Writing – Review & Editing Marjukka 
Myllärniemi: Conceptualization, Methodology, Resources, Writing – Review & Editing, Project 
administration, Funding acquisition Henrik Wolff: Conceptualization, Methodology, Validation, 
Investigation, Writing – Original Draft, Supervision 
 
